Jennifer Viera | executive |
Jay Luly | executive |
Paul Mellett | executive |
Roy Buchanan | analyst |
Roanna Clarissa Ruiz | analyst |
Tara Kieffer | executive |
Eric Joseph | analyst |
Scott Rottinghaus | executive |
Cheng Li | analyst |
Wing Yip | analyst |
Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal First Quarter Financial Results Conference Call. [Operator Instructions]. I would now like to turn the call over to Jennifer Viera, Investor Relations. Please go ahead.
Thank you, Operator, and thanks to everyone for joining us this afternoon.